Abstract:Azilsartan (AZL) is an angiotensin II receptor antagonist, which is mainly used for the treatment of hypertension. AZL has the advantages of high selectivity, hypotensive effect, protection of cardiovascular and cerebrovascular diseases. In order to improve the water solubility of AZL and its bioavailability, AZL -nicotinamide (NA) cocrystal was prepared by mechanical ball milling, and the effect of ball milling conditions on cocrystal preparation were studied. AZL-NA cocrystal was identified and characterized by powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, scanning electron microscopy and Fourier transform infrared spectrometry. The results showed that AZL-NA cocrystal with the molar ratio of 1:2 was successfully prepared. And the optimum ball milling condition was milling speed of 300 rpm, milling time of 50 min, the solvent was ethanol/acetonitrile (1:1, v/v), and the solvent dosage (η) was 0.8 μL/mg. The results of solubility tests showed that the solubility of AZL in the cocrystal was 3.39 times higher than the pure drug at 24 h. And the results of vitro dissolution tests showed that the cumulative dissolution of AZL in 2 h was about 10%. While distilled water, pH 1.2 and pH 4.5 acid or buffered solutions and pH 6.8 buffer phosphate salt solution was used as the dissolution medium, the cumulative dissolution of AZL in cocrystal reached 50%, 35%, 55% and 90%, respectively, showing obvious improvement of dissolution. In addition, the accelerated stability tests showed that the AZL-NA cocrystal had good chemical stability. And the pharmacokinetic results showed that AZL-NA cocrystal could significantly improve the bioavailability of AZL.

Improved Process for Azilsartan Medoxomil: A New Angiotensin Receptor Blocker

Commercial Synthesis of Azilsartan Kamedoxomil: An Angiotensin II Receptor Blocker

An alternative synthesis of Azilsartan: an angiotensin II receptor blocker

Synthesis and characterization of related substances of Azilsartan Kamedoxomil

Recent Advances in the Synthesis and Analysis of Atorvastatin and Its Intermediates

Synthesis of a Novel Angiotensin II Receptor Antagonist Olmesartan Medoxomil

Summary of Synthesis Methods of Olmesartan Medoxomil and Key Intermediates

An Improved Synthesis Of A Beta-Blocker Celiprolol Hydrochloride

A New Reasonable Interpretation of Azilsartan Form II: a Hydrate

New Synthesis Process for the Synthesis of Ezetimibe

Azilsartan-nicotinamide cocrystal: Preparation, characterization and in vitro / vivo evaluation

Efficient Synthesis of Valsartan, A Nonpeptide Angiotensin Ii Receptor Antagonist

Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals

Development and Validation of Stability Indicating Chromatographic Methods for Determination of Azilsartan Medoxomil in Pharmaceutical Formation

Identification, Synthesis, and Comprehension of an Imidazole N-3 Regioisomeric Impurity of Olmesartan Medoxomil Key Intermediate

FORMULATION AND IN VITRO EVALUATION OF AZILSARTAN MEDOXOMIL NANOSUSPENSION

The Organic Process Research of Valsartan

Effect of formulation variables on design, in vitro evaluation of valsartan SNEDDS and estimation of its antioxidant effect in adrenaline-induced acute myocardial infarction in rats

Drug Nanoclusters Formed in Confined Nano-Cages of CD-MOF: Dramatic Enhancement of Solubility and Bioavailability of Azilsartan.

Synthesis method of candesartan cilexetil

Multistep synthesis of a valsartan precursor in continuous flow